Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 15,316.00p on 03-04-2026 at 04:45:09
Change 0.00p 0%
Buy 15,292.00p
Sell 15,288.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Unknown 0.00 at 15,228.5026p
Day's Volume: 0
Last Close: 15,316.00p
Open: 0.00p
ISIN: GB0009895292
Day's Range 0.00p - 0.00p
52wk Range: 9,574.00p - 15,730.00p
Market Capitalisation: £237.53b
VWAP: 0.00p
Shares in Issue: 1.55b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Lower Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 0 15,228.5026p SI Trade
Currency Conversion
 18:52:45 - 02-Apr-26
Unknown* 0 15,248.13377p SI Trade
Currency Conversion
 18:46:00 - 02-Apr-26
Unknown* 0 15,257.94936p SI Trade
Currency Conversion
 18:34:01 - 02-Apr-26
Unknown* 0 15,259.45945p SI Trade
Currency Conversion
 18:33:46 - 02-Apr-26
Unknown* 2 15,253.41909p Currency Conversion
Negotiated Trade
OTC Trade
 18:21:28 - 02-Apr-26
Unknown* 1 15,243.6035p SI Trade
Currency Conversion
 18:18:06 - 02-Apr-26
Unknown* 2 15,245.86864p SI Trade
Currency Conversion
 18:03:34 - 02-Apr-26
Unknown* 0 15,220.19711p SI Trade
Currency Conversion
 17:58:57 - 02-Apr-26
Unknown* 0 15,266.25485p SI Trade
Currency Conversion
 17:33:49 - 02-Apr-26
Buy* 21,351 15,316.00p SI Trade
Negotiated Trade
 17:20:51 - 02-Apr-26
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
3rd Apr 2026 (Fri) 15,316.00 15,316.00 15,316.00 15,316.00 0
2nd Apr 2026 (Thu) 15,042.00 15,436.00 14,956.00 15,316.00 1,608,903
1st Apr 2026 (Wed) 14,896.00 15,100.00 14,868.00 15,022.00 2,678,542
31st Mar 2026 (Tue) 14,710.00 14,856.00 14,660.00 14,690.00 2,535,823
30th Mar 2026 (Mon) 14,438.00 14,752.00 14,322.00 14,702.00 2,270,252
27th Mar 2026 (Fri) 14,114.00 14,508.00 14,006.00 14,302.00 2,680,598
26th Mar 2026 (Thu) 13,922.00 13,982.00 13,768.00 13,830.00 2,338,587
25th Mar 2026 (Wed) 13,930.00 14,080.00 13,842.00 14,062.00 1,560,595
24th Mar 2026 (Tue) 13,728.00 13,856.00 13,646.00 13,810.00 1,399,857
23rd Mar 2026 (Mon) 13,694.00 13,938.00 13,480.00 13,742.00 2,143,472
20th Mar 2026 (Fri) 14,090.00 14,216.00 13,884.00 13,896.00 4,172,253
19th Mar 2026 (Thu) 14,158.00 14,266.00 13,952.00 14,112.00 3,033,173
18th Mar 2026 (Wed) 14,352.00 14,452.00 14,082.00 14,276.00 1,500,922
17th Mar 2026 (Tue) 14,454.00 14,572.00 14,356.00 14,402.00 5,465,035
16th Mar 2026 (Mon) 14,340.00 14,468.00 14,264.00 14,364.00 2,161,262
13th Mar 2026 (Fri) 14,380.00 14,584.00 14,244.00 14,380.00 1,659,198
12th Mar 2026 (Thu) 14,394.00 14,576.00 14,308.00 14,364.00 2,887,687
11th Mar 2026 (Wed) 14,568.00 14,596.00 14,352.00 14,484.00 4,382,330
10th Mar 2026 (Tue) 14,544.00 14,790.00 14,526.00 14,654.00 3,181,998
9th Mar 2026 (Mon) 14,048.00 14,474.00 14,016.00 14,442.00 3,030,806
6th Mar 2026 (Fri) 14,908.00 14,908.00 14,440.00 14,500.00 1,757,032
5th Mar 2026 (Thu) 15,062.00 15,210.00 14,774.00 14,774.00 2,368,076
See more Astrazeneca price history

Astrazeneca (AZN) Regulatory News

Date Source Headline
2nd Apr 2026 7:00 am RNS Imfinzi+Imjudo improves PFS in early liver cancer
1st Apr 2026 3:00 pm RNS Total Voting Rights and Admission of Shares
31st Mar 2026 7:00 am RNS Efzimfotase alfa Ph3 program show positive results
27th Mar 2026 7:00 am RNS Tozorakimab met OBERON/TITANIA primary endpoints
20th Mar 2026 11:00 am RNS Notification of Admission of Shares
16th Mar 2026 7:00 am RNS Imfinzi approved in EU for early gastric cancer
16th Mar 2026 7:00 am RNS Imfinzi approved in EU for early gastric cancer
10th Mar 2026 11:00 am RNS Notice of AGM
10th Mar 2026 11:00 am RNS Notice of AGM
6th Mar 2026 11:10 am RNS Director/PDMR Shareholding
See more Astrazeneca regulatory news

Astrazeneca (AZN) Share News

UK shareholder meetings calendar - next 7 days

2nd Apr 2026 12:07

Read More

AstraZeneca hails encouraging data for liver cancer drug regimen

2nd Apr 2026 10:46

(Alliance News) - AstraZeneca PLC on Thursday posted encouraging phase-three trial results for its liver cancer treatment combination. Read More

AstraZeneca says hypophosphatasia replacement enzyme trials positive

31st Mar 2026 10:03

(Alliance News) - AstraZeneca PLC on Tuesday said phase-three testing of its replacement efzimfotase alfa enzyme on patients affected by hypophosphatasia yielded positive safety and efficacy results. Read More

LONDON MARKET CLOSE: FTSE 100 ends down as oil rises amid war deadlock

27th Mar 2026 17:07

(Alliance News) - Blue chips in London outperformed European and US peers on Friday, but closed marginally lower, as oil prices rose once more amid few signs of progress in ending the Iran war. Read More

LONDON MARKET MIDDAY: Shares slide as Iran tensions deepen

27th Mar 2026 12:02

(Alliance News) - Stock prices in London were lower at midday Friday, with losses accelerating after a muted open as conflicting signals over Iran weighed on sentiment. Read More

See more Astrazeneca news
FTSE 100 Latest
Value10,436.29
Change71.50

Login to your account

Forgot Password?

Not Registered